
Effects of erythropoiesis-stimulating agents on overall survival of International Prognostic Scoring System Low/Intermediate-1 risk, transfusion-independent myelodysplastic syndrome patients: a cohort study
Author(s) -
Emanuela Messa,
Daniela Gioia,
Elisa Masiera,
Anna Castiglione,
Manuela Ceccarelli,
Flavia Salvi,
Paolo Danise,
Alessandro Sanna,
Bernardino Allione,
Enrico Balleari,
Antonella Poloni,
Gianni Cametti,
Dario Ferrero,
Rodolfo Tassara,
Carlo Finelli,
Margherita Bonferroni,
Pellegrino Musto,
Giuseppe Saglio,
Alessandro Levis,
Valeria Santini
Publication year - 2018
Publication title -
haematologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.782
H-Index - 142
eISSN - 1592-8721
pISSN - 0390-6078
DOI - 10.3324/haematol.2017.183590
Subject(s) - international prognostic scoring system , medicine , myelodysplastic syndromes , erythropoiesis , overall survival , cohort , scoring system , oncology , hematology , ineffective erythropoiesis , cohort study , intensive care medicine , anemia , bone marrow